Under a new rule enacted by the Department of Health and Human Services, pharmaceutical companies will soon be required to disclose in television commercials the price of their prescription drugs that cost more than $35 per month (or that same dollar amount for a regular treatment dose).
Drug companies are already required to disclose major and likely side effects in their print and broadcast advertising.
